Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for AFL and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AFL and 80,000+ other tickers.
See exactly how AFL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AFL and 80,000+ other tickers.
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S…
As market volatility and shifting economic conditions test investor resolve, high-quality dividend payers remain a cornerstone for long-term growth and income. Josh Brown – the chief executive of Ritholtz Wealth Management – recently highlighted a trio of industry-leading insurance firms as top dividend stocks to own in 2026: The Travelers Companies, Chubb, and Aflac.
[url="]Niagen Bioscience, Inc.[/url] (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy ag
On January 1, 2026, we published The 3 Best Dividend Aristocrats to Buy in 2026, naming Aflac (NYSE: AFL | AFL Price Prediction), Lowe's (NYSE: LOW), and Nordson (NASDAQ: NDSN) as the three most compelling names on the Aristocrat roster.
COLUMBUS, Ga., June 30, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release second quarter 2026 financial results after the market closes on Thursday, August 6, 2026.
Investors need to pay close attention to AFL stock based on the movements in the options market lately.